Skip to content
OpenCapital
Get started

CTEV CTEV Cumulative Gross Losses and Impairments

Cumulative Gross Losses and Impairments at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
——

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total debt$4.7B+1.1%
Total equity-$241.1M-1,727%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B—
P/S0.6×—

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%—

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by CTEV in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's cumulative gross losses and impairments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's cumulative gross losses and impairments?
CTEV (CTEV) reported cumulative gross losses and impairments of $2.08B in Q1 2026.
How has CTEV's cumulative gross losses and impairments changed year-over-year?
CTEV's cumulative gross losses and impairments decreased by 0.0% year-over-year, from $2.08B to $2.08B.
What is the long-term trend for CTEV's cumulative gross losses and impairments?
Over 2 years (2023 to 2025), CTEV's cumulative gross losses and impairments has grown at a 0.0% compound annual growth rate (CAGR), from $2.08B to $2.08B.
What does cumulative gross losses and impairments mean?
This metric aggregates all unrealized losses and recognized impairment charges on investment securities that have not yet been realized through a sale. It provides a comprehensive view of the negative valuation adjustments impacting the bank's equity. It is a key indicator of the credit and market risk embedded in the bank's long-term holdings.